Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.
about
HIV: inflammation and boneBone health in HIV and hepatitis B or C infectionsAgeing and inflammation in patients with HIV infection.Elevated suppressor of cytokine signaling-1 (SOCS-1): a mechanism for dysregulated osteoclastogenesis in HIV transgenic ratsHypocalcaemia, alcohol drinking and viroimmune responses in ART recipients.Bone mineral density in children and adolescents with perinatal HIV infectionAging, human immunodeficiency virus, and bone health.Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infectionT-cells and B-cells in osteoporosisDo γδ T cells predict osteonecrosis of the jaw?Association of Blood Biomarkers of Bone Turnover in HIV-1 Infected Individuals Receiving Anti-Retroviral Therapy (ART)Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.B Cell Production of Both OPG and RANKL is Significantly Increased in Aged MiceBioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo.Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.Premature expression of a muscle fibrosis axis in chronic HIV infectionVitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.Complete manuscript Title: Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults.HIV and its effects on bone: a primer for rheumatologistsTrauma-induced heterotopic bone formation and the role of the immune system: A reviewAntiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infectionHIV and bone metabolismOSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.Immunology of Osteoporosis: A Mini-Review.HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.Bone health in children and adolescents with perinatal HIV infectionBody composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individualsThe Interplay between the bone and the immune systemAdverse bone health among children and adolescents growing up with HIV.Does systemic inflammation and immune activation contribute to fracture risk in HIV?Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection.Comparative risk of fracture in men and women with HIV.Bio-active engineered 50 nm silica nanoparticles with bone anabolic activity: therapeutic index, effective concentration, and cytotoxicity profile in vitro.Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model.HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options.Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing.Bone health and HIV in resource-limited settings: a scoping review.
P2860
Q27010898-08F1C786-D462-4B41-AFB8-C4F4CD1200D9Q30238946-795B484A-3E3A-424F-BA67-A9323B8105EAQ30244296-9435F604-2D0E-426B-9527-64C4EE904426Q33723186-8BFB3412-B807-4088-8D87-C629841B3214Q33981464-2DF79EB3-FABC-41B9-A6A7-AB7D43A6D389Q34150394-15CD2C0A-924C-4C6C-B1C3-5642916E4F25Q34160511-4A599A7C-2359-4103-AEE2-ED5B84103B52Q34506677-196DF63A-306A-4807-BDF7-37FEBA5540CCQ35035665-CE6AD0D5-40D1-4A86-82EC-3C8D79CCB5DDQ35046087-7715740D-8A37-49F3-AB95-298A22EF9482Q35096244-2F717FEB-C0E5-4B73-92D5-B4D33588AA3CQ35124970-906B8EA1-253E-4186-9B95-D5F6BBE0E879Q35598428-C0C643BE-205A-461F-92CE-FBCC418F29F6Q35795104-10E3D9D3-411F-4200-B8A4-FAD8E29CA001Q36087907-4F254806-84D5-405A-80AA-E0DF921374EEQ36125412-AAE4DB7B-1CA6-41D6-BDE4-AA83CB46D89AQ36170370-06782A81-6AB1-4B23-A144-B91B79AB4663Q36343699-C914B694-6E8E-4C53-B803-3C891CC36C64Q36381079-DFAB7D16-1FAA-4CD4-BDAF-69A649A9FCDAQ36395829-F909AABD-DDE6-4D59-AA61-DCF302293043Q36462148-4848D8B5-F958-440F-BB2D-B143A57A96E6Q36671233-3EC35922-1D50-4605-985F-105AF62B75B8Q36739654-DF70D267-B88C-48E3-88A0-FBAB3A71C1E4Q36766801-5E197177-6817-4BB7-95A4-3FCC54AC9662Q36783435-4B5EEAFD-24E5-4C6C-BC8A-EB395FD066F2Q36941678-6C648423-0A22-46E5-817E-2B7267045535Q36958022-4CBA5475-9210-4E7D-9A9B-89CD293B0CAFQ37052226-A074B492-645F-4694-9594-C4FCD1DEAD0BQ37098360-2FD8B153-8D45-44BD-8060-11E6DBCE77D8Q37138907-0E802A95-FE20-4D9B-A26D-BE3E9701B6ECQ37172356-08494656-2014-4172-A53A-FE4226BE85A3Q37287589-C408D707-A6FB-40AB-B0A4-8D5922439061Q37344527-61BEED99-6310-4B64-A07B-1812153741DAQ37554792-273F6D5F-0958-427D-A4CB-48D7E14AB72DQ37588362-2A5C0092-5149-4967-B34A-361FFAFED6C0Q37589696-EEBAF26E-7D9A-4107-84DE-DBABF3198BF3Q37715449-622D9679-A65C-40CE-9B35-CED92152A259Q38055705-863D57F0-79B5-4867-BE9F-7E0BD7D3A5BFQ38177684-7D6493C4-AB4B-4203-8A4A-5045BD1216A2Q38792298-524711F1-F0F7-41AB-8009-EB4A9E464B4F
P2860
Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@ast
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@en
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@nl
type
label
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@ast
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@en
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@nl
prefLabel
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@ast
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@en
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@nl
P2093
P2860
P356
P1476
Alterations in the immuno-skel ...... tion in HIV-1 transgenic rats.
@en
P2093
David M Guidot
Ighovwerha Ofotokun
M Neale Weitzmann
Majd Zayzafoon
Masayoshi Yamaguchi
Susanne Roser-Page
Tatyana Vikulina
P2860
P304
13848-13853
P356
10.1073/PNAS.1003020107
P407
P577
2010-07-19T00:00:00Z